Famotidine Injection, Solution
NDC 25021-755
Product Information
Famotidine is a NDA-approved product labeled by Sagent Pharmaceuticals. This medication is typically used as a histamine h2 receptor antagonists [moa]. It is supplied as a injection, solution for intravenous administration. This product entry covers the primary NDC 25021-755 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 25021-755?
What are the uses of this product?
What are Active Ingredients of this product?
- FAMOTIDINE 4 mg/mL - A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- FAMOTIDINE (UNII: 5QZO15J2Z8)
- FAMOTIDINE (UNII: 5QZO15J2Z8) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- ASPARTIC ACID (UNII: 30KYC7MIAI)
- MANNITOL (UNII: 3OWL53L36A)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- WATER (UNII: 059QF0KO0R)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 2727402 - famotidine 4 MG/ML Injectable Solution
- RxCUI: 2727403 - famotidine 20 MG in 5 ML Injection
- RxCUI: 2727403 - 5 ML famotidine 4 MG/ML Injection
- RxCUI: 2727403 - famotidine 20 MG per 5 ML Injection
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.